AXGN
Axogen, Inc. · Healthcare · Market cap $2.0B
Insiders sold $4.7M net in the last 90 days ·4 sellers, 0 buyers· 4 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 4, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19.3M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Latest filing
Sep 4, 2026
TYNDALL JOSEPH A.
Axogen, Inc. (AXGN) has 45 SEC Form 4 filings (100 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Sep 4, 2026.
Inside the rolling window, 12 insiders at Axogen, Inc. reported no open-market purchases and 32 open-market sales totaling $19.3M. The most active filer is Director Burke William P. Mr. with 7 filings. Insiders have net sold $6.5M over the trailing 6 months. The most recent open-market filing is a sale of 3,500 shares by Director TYNDALL JOSEPH A., dated Sep 2, 2026, worth $174K.
- Industry:Medical - Devices
- CEO:Michael D. Dale
- Employees:622
- HQ:Alachua, FL, US
- IPO:1986-12-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
TYNDALL JOSEPH A.First in 9 months | Director | Sale | 3,500 | $174K | Sep 4 | -24.4% | SEC ↗ |
Wendell Amy McBrideFirst in 3 months | Director | Sale | 13,353 | $647K | Aug 12 | -26.6% | SEC ↗ |
Began Marc AFirst in 8 months | EVP & General Counsel | Sale | 67,500 | $3.2M | Aug 12 | -26.6% | SEC ↗ |
Weiler Kathy JohnsonFirst in 3 months | Director | Sale | 14,150 | $641K | Aug 11 | -24.8% | SEC ↗ |
| Director | Sale | 1,647 | $70K | May 12 | -10.9% | SEC ↗ | |
Hartley Lindsey MarieFirst in 5 months | CFO | Sale | 1,051 | $46K | May 8 | -13.3% | SEC ↗ |
Weiler Kathy JohnsonFirst in 5 months | Director | Sale | 16,344 | $721K | May 8 | -13.3% | SEC ↗ |
JOHNSON JOHNFirst in 5 months | Director | Sale | 11,050 | $478K | May 8 | -13.3% | SEC ↗ |
Kemp JensFirst in 5 months | Chief Marketing Officer | Sale | 4,000 | $174K | May 8 | -13.3% | SEC ↗ |
Quackenbush DorisFirst filing | Sales VP | Sale | 3,878 | $169K | May 8 | — | SEC ↗ |
DeVinney Erick WayneFirst in 3 months | Chief Innovation Officer | Sale | 5,221 | $171K | Mar 18 | — | SEC ↗ |
Weiler Kathy JohnsonFirst filing | Director | Sale | 46,653 | $1.4M | Dec 17 | — | SEC ↗ |
Wendell Amy McBrideFirst filing | Director | Sale | 43,684 | $1.3M | Dec 17 | — | SEC ↗ |
| CFO | Sale | 14,812 | $442K | Dec 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 25,000 | $750K | Dec 12 | — | SEC ↗ | |
| EVP & General Counsel | Sale | 13,222 | $397K | Dec 12 | — | SEC ↗ | |
JOHNSON JOHNFirst filing | Director | Sale | 23,693 | $740K | Dec 10 | — | SEC ↗ |
JOHNSON JOHNFirst filing | Director | Sale | 21,686 | $650K | Dec 10 | — | SEC ↗ |
Hartley Lindsey MarieFirst filing | CFO | Sale | 14,387 | $454K | Dec 10 | — | SEC ↗ |
TYNDALL JOSEPH A.First filing | Director | Sale | 25,108 | $778K | Dec 10 | — | SEC ↗ |
DALE MICHAEL DFirst filing | Chief Executive Officer | Sale | 61,463 | $1.9M | Dec 10 | — | SEC ↗ |
Kemp JensFirst filing | Chief Marketing Officer | Sale | 8,156 | $255K | Dec 10 | — | SEC ↗ |
DeVinney Erick WayneFirst filing | Chief Innovation Officer | Sale | 19,517 | $609K | Dec 10 | — | SEC ↗ |
Began Marc AFirst filing | EVP & General Counsel | Sale | 9,278 | $290K | Dec 10 | — | SEC ↗ |
THOMAS PAULFirst filing | Director | Sale | 21,399 | $634K | Dec 10 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading AXGN 2 all-time
- DRep. Donna ShalalaPurchase$1,001 - $15,0002019-04-16
- DRep. Donna ShalalaOther$1,001 - $15,0002019-06-24
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does AXGN have?
Axogen, Inc. (AXGN) has 45 SEC Form 4 filings (100 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for AXGN?
The most recent Form 4 filing for AXGN on Tracefour is dated Sep 4, 2026.
Who is the most active insider at AXGN?
The most active SEC Form 4 filer at AXGN in the rolling window is Director Burke William P. Mr., with 7 filings.
What is the net insider flow at AXGN over the last 6 months?
Over the trailing 180 days, insiders at AXGN have net sold $6.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AXGN in the current window?
Inside the rolling window, insiders at AXGN bought $0 and sold $19.3M based on SEC Form 4 filings.
Can I get alerts for AXGN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Axogen, Inc. (AXGN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Axogen, Inc. is in the Healthcare sector.